Valuation GSK plc Sao Paulo

Stocks

Delayed Sao Paulo 09:09:45 2026-08-17 EDT			5-day change	1st Jan Change
52.00 ^BRL	+0.06%		+3.98%	-4.15%

04:59am	GSK plc : Deutsche Bank remains Neutral	ZD
08-17	Chugai grants GSK exclusive global license for AID351 dengue antibody	AN

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	75,652	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	3.35%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	94,853	92,025	88,978
Change	-	-24.65%	-1.89%	-8.24%	28.83%	8.21%	-2.98%	-3.31%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	14.3x	11.7x	10.9x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.59x	3.98x	3.48x
PEG	-	0x	-0.2x	-0.4x	0x	-2.29x	0.5x	1.57x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.23x	2.13x	2.06x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.79x	2.59x	2.43x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.27x	7.49x	6.99x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.21x	8.31x	7.7x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	17.1x	15.9x	13.1x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	5.85%	6.29%	7.64%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7495	0.7831
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.69%	3.97%	4.15%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.323	1.616	1.728
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	52.6%	46.4%	45.3%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,942	35,540	36,692
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,467	12,286	12,727
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,301	11,074	11,551
Net income ¹	4,385	14,956	4,928	2,575	5,716	5,436	6,484	6,933
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	19,200	16,373	13,325
Reference price ²	20.08	14.38	14.50	13.46	18.24	18.88	18.88	18.88
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,007,011	-	-
Announcement Date	2/9/22	2/1/23	1/31/24	2/5/25	2/4/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.07x	12.64x	25.79x	0.56%	1,093B
JOHNSON & JOHNSON	30.16x	-	-	1.98%	653B
ABBVIE INC.	33.05x	7.66x	15.93x	2.65%	458B
ROCHE HOLDING AG	20.11x	4.77x	11.83x	2.77%	355B
NOVARTIS AG	21.93x	5.66x	14.07x	2.83%	294B
ASTRAZENECA PLC	20.48x	4.23x	12x	2.08%	248B
AMGEN INC.	26.9x	6.98x	12.39x	2.37%	230B
NOVO NORDISK A/S	13.48x	4.8x	10.06x	3.81%	203B
GILEAD SCIENCES, INC.	-43.83x	6.34x	24.76x	2.3%	178B
Average	17.48x	6.63x	15.85x	2.37%	412.27B
Weighted average by Cap.	25.04x	8.32x	18.34x	1.93%